Cargando…
Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation
Tumour metastasis is the main cause of postoperative tumour recurrence and mortality in patients with hepatocellular carcinoma (HCC), but the underlying mechanism remains unclear. Accumulating evidence has demonstrated that programmed cell death 10 (PDCD10) plays an important role in many biological...
Autores principales: | Sun, Bo, Zhong, Fang-Jing, Xu, Cong, Li, Yi-Ming, Zhao, Yan-Rong, Cao, Mo-Mo, Yang, Lian-Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440642/ https://www.ncbi.nlm.nih.gov/pubmed/34521817 http://dx.doi.org/10.1038/s41419-021-04139-z |
Ejemplares similares
-
MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017) -
Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1
por: Deng, Jianyong, et al.
Publicado: (2023) -
Fluid shear stress activates YAP to promote epithelial–mesenchymal transition in hepatocellular carcinoma
por: Yu, Hongchi, et al.
Publicado: (2021) -
Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014) -
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)